CCC vs REGN · P/E 78, rev $944.8M vs P/E 14, rev $14.34B
CCC Intelligent Solutions Holdings Inc. (CCC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
CCC Intelligent Solutions Holdings Inc. (CCC) is a software - application company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CCC revenue for 2024-12-31 was $944.8M. Net income was $31.2M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. CCC currently screens at market cap $2.74B and trailing P/E 77.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CCC currently screens at market cap $2.74B and trailing P/E 77.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CCC and REGN stock pages for the full models.
Not investment advice.